Post Marketing Surveillance (PMS) refers to the monitoring of pharmaceutical products, medical devices, and other healthcare interventions after they have been released on the market. The primary goal is to ensure ongoing patient safety and to detect any adverse effects that were not identified during clinical trials. PMS is a critical component in the lifecycle of a product and involves various stakeholders, including healthcare professionals, regulatory authorities, and patients.
